Topical Collection on Neuromuscular Blockade
In this topical collection (32 articles)
-
Neuromuscular Blockade (CA Lien, Section Editor)
Monitoring the Depth of Neuromuscular Blockade
Larry Lindenbaum MD, Bradley J. Hindman MD… Pages 1-7 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Incidence and Risk Factors for Postoperative Residual Neuromuscular Blockade
Roy Soto Pages 81-84 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Evaluation of the Efficacy and Safety of Neostigmine in Reversing Neuromuscular Blockade
D. Schmartz, P. Bernard, R. Sghaier, T. Fuchs-Buder Pages 85-89 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Clinical Practice Guideline for the Management of Neuromuscular Blockade: What Are the Recommendations in the USA and Other Countries?
Réka Nemes, J. Ross Renew Pages 90-98 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Deep Neuromuscular Blockade: Does the Data Support Its Use in Surgical Patients?
Rohit Jain, Thomas Ledowski Pages 99-106 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Management of Neuromuscular Blockade in the Elderly and Morbidly Obese Patient: What Does the Data Show?
J. Ross Renew, Mohamed Naguib Pages 107-116 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Detecting Residual Weakness: an Update on Quantitative Neuromuscular Monitoring
Vivian Hernandez-Torres, J. Ross Renew Pages 117-122 -
Neuromuscular Blockade (GS Murphy, Section Editor)
New Drug Developments for Neuromuscular Blockade and Reversal: Gantacurium, CW002, CW011, and Calabadion
Hans Donald de Boer, Ricardo Vieira Carlos Pages 119-124 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Sugammadex and Hypersensitivity-Related Reactions: a Review
Robert J. Gregory, Harvey Woehlck, Cynthia A. Lien Pages 123-130 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Mivacurium: a Review
Lisa S. Molloy, Thomas Ledowski Pages 125-129 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Qualitative Neuromuscular Monitoring: Patterns of Stimulation, Site of Monitoring, and Accuracy in Detecting Residual Neuromuscular Blockade
Moumen Asbahi, Roy Soto Pages 130-133 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Residual Neuromuscular Blockade and Postoperative Pulmonary Complications: What Does the Recent Evidence Demonstrate?
Guy Cammu Pages 131-136 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Quantitative Neuromuscular Monitoring: Current Devices, New Technological Advances, and Use in Clinical Practice
Hajime Iwasaki, Reka Nemes, Sorin J. Brull, J. Ross Renew Pages 134-144 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Neostigmine: Mechanism of Action, Dosing, and Factors Determining Adequacy of Recovery Following Administration
Pierre-Edouard Lorrain, Denis Schmartz… Pages 145-149 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Should Neuromuscular Blockade Be Routinely Reversed?
Julien Raft, Claude Meistelman Pages 150-156 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Neuromuscular Blocking Drugs and Postoperative Pulmonary Complications
Letha Mathews, Jesse M. Ehrenfeld Pages 157-160 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Dosing, Monitoring, and Reversal of Neuromuscular Blockade: Are Anesthesiologists Following Evidence-Based Practices?
Moumen Asbahi, Roy Soto Pages 160-163 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Profound Neuromuscular Blockade: Advantages and Challenges for Patients, Anesthesiologists, and Surgeons
Cynthia A. Lien Pages 161-167 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade
Stephan R. Thilen, Sanjay M. Bhananker Pages 164-169 -
Neuromuscular Blockade (GS Murphy, Section Editor)
Sugammadex: Clinical Pharmacokinetics and Pharmacodynamics
Jennifer Nguyen-Lee, Natalie Moreland, Alireza Sadoughi… Pages 168-177
Continue reading...
To view the rest of this content please follow the download PDF link above.
